Interaction Studies of Hexameric and Pentameric IgMs with Serum-Derived C1q and Recombinant C1q Mimetics

Maria Magdalena John,Monika Hunjadi,Vanessa Hawlin,Jean-Baptiste Reiser,Renate Kunert

DOI: https://doi.org/10.3390/life14050638

2024-05-18

Life

Abstract:The interaction between IgM and C1q represents the first step of the classical pathway of the complement system in higher vertebrates. To identify the significance of particular IgM/C1q interactions, recombinant IgMs were used in both hexameric and pentameric configurations and with two different specificities, along with C1q derived from human serum (sC1q) and two recombinant single-chain variants of the trimeric globular region of C1q. Interaction and complement activation assays were performed using the ELISA format, and bio-layer interferometry measurements to study kinetic behavior. The differences between hexameric and pentameric IgM conformations were only slightly visible in the interaction assay, but significant in the complement activation assay. Hexameric IgM requires a lower concentration of sC1q to activate the complement compared to pentameric IgM, leading to an increased release of C4 compared to pentameric IgM. The recombinant C1q mimetics competed with sC1q in interaction assays and were able to inhibit complement activation. The bio-layer interferometry measurements revealed KD values in the nanomolar range for the IgM/C1q interaction, while the C1q mimetics exhibited rapid on and off binding rates with the IgMs. Our results make C1q mimetics valuable tools for developing recombinant C1q, specifically its variants, for further scientific studies and clinical applications.

biology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to study the differences in the interactions between hexameric and pentameric IgM with serum - derived C1q and recombinant C1q mimetics, and the impact of these differences on the activation of the complement system. Specifically, the researchers focus on the following aspects: 1. **Interaction between IgM and C1q**: By using recombinant IgM (in hexameric and pentameric forms) and two antibodies with different specificities, combined with serum - derived C1q (sC1q) and the trimeric globular regions of C1q of two recombinant single - chain variants, the interaction between IgM and C1q is studied. 2. **Activation of the complement system**: Evaluate the differences in the efficiency of different forms of IgM in activating the complement system, especially the performance of hexameric IgM and pentameric IgM in activating C4 cleavage. 3. **Role of C1q mimetics**: Study the competitive ability of C1q mimetics (ACB and AD2) in the interaction between IgM and C1q, and their inhibitory effects on the activation of the complement system. Through these studies, the authors hope to reveal how different conformations of IgM affect their interaction with C1q and their role in the activation of the complement system, thereby providing a scientific basis for the development of recombinant C1q and its variants, and promoting its further development in scientific research and clinical applications.

Interaction Studies of Hexameric and Pentameric IgMs with Serum-Derived C1q and Recombinant C1q Mimetics

The Fc fragment of soluble IgMs binds C1q to activate the classical complement pathway, while inhibiting complement-dependent cytotoxicity

A Microcalorimetric Study of Molecular Interactions Between Immunoglobulin G and Hydrophobic Charge-Induction Ligand

Complement activation by IgG subclasses is governed by their ability to oligomerize upon antigen binding

The Solvent at Antigen-Binding Site Regulated C3d-CR2 Interactions Through the C-terminal Tail of C3d at Different Ion Strengths: Insights from Molecular Dynamics Simulation.

The Human IgM Pentamer is a Mushroom-Shaped Molecule with a Flexural Bias

Selection and characterization of a peptide-based complement modulator targeting C1 of the innate immune system

Structural Insights into Immunoglobulin M

Chimeric Proteins Containing MAP-1 and Functional Domains of C4b-Binding Protein Reveal Strong Complement Inhibitory Capacities

Antibody density on bacteria regulates C1q recruitment by monoclonal IgG but not IgM

Glycan-independent Binding and Internalization of Human IgM to FCMR, Its Cognate Cellular Receptor

gC1qR/C1qBP/HABP-1: Structural Analysis of the Trimeric Core Region, Interactions With a Novel Panel of Monoclonal Antibodies, and Their Influence on Binding to FXII

New Insights into the Complement Receptor of the Ig Superfamily Obtained from Structural and Functional Studies on Two Mutants

Endogenous complement-activating IgM is not required for primary antibody responses but promotes plasma cell differentiation and secondary antibody responses to a large particulate antigen in mice

Complement Is Activated by IgG Hexamers Assembled at the Cell Surface

Regulation of antibody-mediated complement-dependent cytotoxicity by modulating the intrinsic affinity and binding valency of IgG for target antigen

An ELISA for detection of complement-bound circulating immune complexes in mice

Developing the IVIG Biomimetic, Hexa-Fc, for Drug and Vaccine Applications

Mechanistic insights into inter-chain disulfide bond reduction of IgG1 and IgG4 antibodies

Reconstitution of the alternative pathway of the complement system enables rapid delineation of the mechanism of action of novel inhibitors

Interchain Disulfide Bonding in Human IgG2 Antibodies Probed by Site-Directed Mutagenesis